Saturday, April 4, 2015 - Lawyers handling testosterone lawsuit claims report a surge in the number of cases now involved in the multidistrict litigation for testosterone replacement therapies underway in U.S. District Court in the Northern District of Illinois. The case, known as Testosterone Replacement Product Liability Litigation - MDL No. 2545, now includes a total of 1,358 cases, according to recent court documents.
Last week, a new action was transferred for inclusion in the pretrial proceedings with the other national testosterone lawsuits, according to court documents. Known as Carter v. Actavis (Case No. 15cv2607), the lawsuit was transferred from U.S. District Court in New Jersey. This transfer brought the number of pending cases to 1358. All of these cases have been filed by or on behalf of men who allegedly suffered from heart attack, stroke, or another serious health problem while taking a testosterone replacement therapy product, according to court documents. Attorneys providing testosterone lawsuit representation anticipate that this number will continue to climb as the case gains greater national visibility.
The multidistrict litigation was established in June 2014 when 8 separate actions were transferred to the Northern Illinois District for pretrial proceedings on the basis of common questions of fact, according to court documents. While the initial claims only included allegations of heart attack, stroke and other serious health conditions linked to the testosterone drug Androgel, the MDL has been expanded to include testosterone lawsuits for a number of drugs, according to court documents. The complaints were deemed similar enough as to make the consolidation of pretrial proceedings desirable, despite the fact that the defendant list grew from a single company (AbbVie, the manufacturer of Androgel) to include many others, according to court documents. The list of defendants now includes AbbVie/Abbott, Auxilium, Lilly, Watson/Actavis, Endo, and Pfizer, according to court documents.
The next scheduled court proceeding in the testosterone lawsuits is a Case Management Conference scheduled for April 21, 2015 at 1:30 pm. Depositions procedures were the subject of the March case management conference, according to court documents. The presiding judge, the Honorable Matthew F. Kennelly, has set forth a schedule that has bellweather cases concluded by April of 2017. Bellweather cases are representative testosterone lawsuits that will set a precedent for all the other lawsuits now involved in the testosterone litigation.
Lawyers representing men and families around the nation in testosterone lawsuits believe that individuals and the families of individuals who experienced heart attack, stroke, or another serious health problem while taking testosterone may be entitled to real compensation by filing a testosterone lawsuit. Nationally-renowned for groundbreaking work in drug and product safety litigation against multi-billion dollar corporations, the Onder Law Firm‘s testosterone attorneys have committed their significant resources to providing expert legal representation to men and the family members of men who believe they may have grounds to file testosterone lawsuits. Individuals and family members of individuals who meet this description are entitled to a no-cost, no-obligation consultation through the firm‘s Testim Testosterone Lawsuit Center website.
The Onder Law Firm welcomes testosterone lawsuit or other testosterone case inquiries from law firms in regards to handling them or working as co-counsel.